Skip to main content
Erschienen in: Journal of Cancer Education 3/2016

08.07.2015

Medical Student Knowledge of Oncology and Related Disciplines: a Targeted Needs Assessment

verfasst von: Jonathan Oskvarek, Steve Braunstein, Jeanne Farnan, Mark K. Ferguson, Olwen Hahn, Tara Henderson, Susan Hong, Stacie Levine, Carol A. Rosenberg, Daniel W. Golden

Erschienen in: Journal of Cancer Education | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Despite increasing numbers of cancer survivors, non-oncology physicians report discomfort and little training regarding oncologic and survivorship care. This pilot study assesses medical student comfort with medical oncology, surgical oncology, radiation oncology, hospice/palliative medicine, and survivorship care. A survey was developed with input from specialists in various fields of oncologic care at a National Cancer Institute-designated comprehensive cancer center. The survey included respondent demographics, reports of experience with oncology, comfort ratings with oncologic care, and five clinical vignettes. Responses were yes/no, multiple choice, Likert scale, or free response. The survey was distributed via email to medical students (MS1–4) at two US medical schools. The 105 respondents were 34 MS1s (32 %), 15 MS2s and MD/PhDs (14 %), 26 MS3s (25 %), and 30 MS4s (29 %). Medical oncology, surgical oncology, and hospice/palliative medicine demonstrated a significant trend for increased comfort from MS1 to MS4, but radiation oncology and survivorship care did not. MS3s and MS4s reported the least experience with survivorship care and radiation oncology. In the clinical vignettes, students performed the worst on the long-term chemotherapy toxicity and hospice/palliative medicine questions. Medical students report learning about components of oncologic care, but lack overall comfort with oncologic care. Medical students also fail to develop an increased self-assessed level of comfort with radiation oncology and survivorship care. These pilot results support development of a formalized multidisciplinary medical school oncology curriculum at these two institutions. An expanded national survey is being developed to confirm these preliminary findings.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Potosky AL, Han PKJ, Rowland J et al (2011) Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 26:1403–1410. doi:10.1007/s11606-011-1808-4 CrossRefPubMed Potosky AL, Han PKJ, Rowland J et al (2011) Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 26:1403–1410. doi:10.​1007/​s11606-011-1808-4 CrossRefPubMed
5.
Zurück zum Zitat Barton MB, Simons RG (1999) A survey of cancer curricula in Australian and New Zealand medical schools in 1997. Oncology Education Committee of the Australian Cancer Society. Med J Aust 170:225–227PubMed Barton MB, Simons RG (1999) A survey of cancer curricula in Australian and New Zealand medical schools in 1997. Oncology Education Committee of the Australian Cancer Society. Med J Aust 170:225–227PubMed
6.
Zurück zum Zitat DeNunzio NJ, Joseph L, Handal R et al (2013) Devising the optimal preclinical oncology curriculum for undergraduate medical students in the United States. J Cancer Educ Off J Am Assoc Cancer Educ 28:228–236. doi:10.1007/s13187-012-0442-0 CrossRef DeNunzio NJ, Joseph L, Handal R et al (2013) Devising the optimal preclinical oncology curriculum for undergraduate medical students in the United States. J Cancer Educ Off J Am Assoc Cancer Educ 28:228–236. doi:10.​1007/​s13187-012-0442-0 CrossRef
7.
Zurück zum Zitat Kwan JYY, Nyhof-Young J, Catton P, Giuliani ME (2015) Mapping the future: towards oncology curriculum reform in undergraduate medical education at a Canadian medical school. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2014.11.017 PubMed Kwan JYY, Nyhof-Young J, Catton P, Giuliani ME (2015) Mapping the future: towards oncology curriculum reform in undergraduate medical education at a Canadian medical school. Int J Radiat Oncol Biol Phys. doi:10.​1016/​j.​ijrobp.​2014.​11.​017 PubMed
8.
Zurück zum Zitat Flinders DJ, Noddings N, Thornton SJ (1986) The null curriculum: its theoretical basis and practical implications. Curric Inq 16:33–42. doi:10.2307/1179551 CrossRef Flinders DJ, Noddings N, Thornton SJ (1986) The null curriculum: its theoretical basis and practical implications. Curric Inq 16:33–42. doi:10.​2307/​1179551 CrossRef
11.
Zurück zum Zitat Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582CrossRefPubMed Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582CrossRefPubMed
12.
Zurück zum Zitat Silver JK, Baima J, Mayer RS (2013) Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship. CA Cancer J Clin 63:295–317CrossRefPubMed Silver JK, Baima J, Mayer RS (2013) Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship. CA Cancer J Clin 63:295–317CrossRefPubMed
Metadaten
Titel
Medical Student Knowledge of Oncology and Related Disciplines: a Targeted Needs Assessment
verfasst von
Jonathan Oskvarek
Steve Braunstein
Jeanne Farnan
Mark K. Ferguson
Olwen Hahn
Tara Henderson
Susan Hong
Stacie Levine
Carol A. Rosenberg
Daniel W. Golden
Publikationsdatum
08.07.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 3/2016
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0876-2

Weitere Artikel der Ausgabe 3/2016

Journal of Cancer Education 3/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.